Story
"For the price of a decent planning report or a bit of due diligence, we can make a real difference to the lives of people who, up until now, have only been told there’s nothing that can be done for them."
I am asking for your help to raise £25,000 that being the cost of buying, importing and installing a GigerMD in the UK and training staff to operate it. You don’t have to promise all of that yourself of course, but anything, anything at all that you can give would make a tremendous difference not only to me, but to anybody who has a neurological condition of any sort. And that’s an awful lot of people who would be immensely grateful to you.
I have developed a rare medical condition known as MSA - a neurodegenerative disease that medical science
can’t yet cure, treat or even slow down. Basically, MSA just munches away at
one’s nervous system until there is nothing left to munch. At which point, you
lose. I have had symptoms for several years but have now reached the point
where working is no longer feasible.
While medical science can't cure MSA, the GigerMD machine helps the body to reassign
healthy nerve tissue to replace tissues damaged or destroyed by accident or
disease. It’s not a cure, because eventually the body runs out of healthy nerve
tissue to convert, but it is a way of making the very best use of what one has.
Stoke Mandeville Hospital
have one of the only machines in the public domain in the UK, and their
Clinical Director recently wrote to me to say: “we find the GIGER to be an extremely useful part of the ongoing
maintenance for health for people with neurological disability.”
I mentioned the GigerMD to Benfleet Physiotherapy, the
neuro-physiotherapy practice that I attend and they, having consulted with
numerous senior practitioners, were very enthusiastic about the device. So much
so they agreed that if we could raise the money to buy one, they would locate
it within their practice and not only offer therapy to MSA sufferers free of
charge, but also provide rehabilitation services to anyone suffering with a
neurological condition.
Quite apart from the treatment angle, there is also the
possibility that the data obtained from treatment would have a value in MSA
research, an area that needs much more support.
This is probably the most cost effective project I’ve ever been
involved with. For the price of a decent planning report or a bit of due
diligence, we can make a real difference to the lives of people who, up until
now, have only been told there’s nothing that can be done for them. That’s got
be worthwhile.
Thank you.
Andrew